GOLDSTEIN DOV A MD

Chief Financial Officer at VICURON PHARMACEUTICALS INC · on record since Sep 5, 2003
Director at MELINTA THERAPEUTICS, INC. /NEW/ · on record since Mar 23, 2012
Director at ADMA BIOLOGICS, INC. · on record since Feb 15, 2012
Chief Financial Officer at BioAge Labs, Inc. · on record since Apr 24, 2026
Director at Durata Therapeutics, Inc. · on record since Jul 25, 2012
10% owner at Durata Therapeutics, Inc. · on record since Jul 25, 2012
Director at Loxo Oncology, Inc. · on record since Jul 31, 2014
CFO and Treasurer at Loxo Oncology, Inc. · on record since Jul 31, 2014
10% owner at Loxo Oncology, Inc. · on record since Jul 31, 2014
10% owner at ADMA BIOLOGICS, INC. · on record since Feb 16, 2017
Director at NeuBase Therapeutics, Inc. · on record since Jul 16, 2019
Director at Gain Therapeutics, Inc. · on record since Mar 17, 2021
Director at Coya Therapeutics, Inc. · on record since Dec 28, 2022
Director at Esperion Therapeutics, Inc. · on record since Jun 25, 2013

Insider trading activity of GOLDSTEIN DOV A MD

Transactions on record: 120; since Sep 5, 2003

Open-market buys: 8; $26.1M

Open-market sells: 16; $63.3M

Companies traded: 10; last filing Jul 17, 2026

Figures computed from official regulatory filings — .

Companies where GOLDSTEIN DOV A MD has traded

Gain Therapeutics, Inc.5 tx · Jul 17, 2026
BioAge Labs, Inc.16 tx · $820.4K · Apr 24, 2026
8 tx · $19.1K · Jan 6, 2026
7 tx · $158K · Sep 12, 2022
10 tx · May 1, 2020
26 tx · $60.5M · Jun 8, 2018
26 tx · $13.2M · Mar 9, 2017
12 tx · $5.6M · Apr 3, 2015
3 tx · $10M · Jul 25, 2012
7 tx · $1.9K · Sep 10, 2004

Track record of GOLDSTEIN DOV A MD

Statistical track record

Free account

Open-market buys: 9

Last buy: Jan 3, 2023

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of GOLDSTEIN DOV A MD

Co-insiders of GOLDSTEIN DOV A MD

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Gain Therapeutics, Inc.Listing on record	Jul 17, 2026	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Apr 24, 2026	ExerciseD (derivative)	-3,542	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Apr 24, 2026	Exercise	3,542	4.38 USD	$15.5K		SEC
BioAge Labs, Inc.Listing on record	Mar 3, 2026	ExerciseD (derivative)	-3,542	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Mar 3, 2026	Exercise	3,542	4.38 USD	$15.5K		SEC
BioAge Labs, Inc.Listing on record	Feb 19, 2026	AwardD (derivative)	110,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Feb 3, 2026	ExerciseD (derivative)	-3,541	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Feb 3, 2026	Exercise	3,541	4.38 USD	$15.5K		SEC
BioAge Labs, Inc.Listing on record	Jan 21, 2026	ExerciseD (derivative)	-3,542	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Jan 21, 2026	Exercise	3,542	4.38 USD	$15.5K		SEC
BioAge Labs, Inc.Listing on record	Jan 15, 2026	Sell	-8,974	18.43 USD	$165.4K		SEC
BioAge Labs, Inc.Listing on record	Jan 15, 2026	Sell	-1,923	21.08 USD	$40.5K		SEC
BioAge Labs, Inc.Listing on record	Jan 15, 2026	ExerciseD (derivative)	-27,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Jan 15, 2026	Exercise	27,000	8.39 USD	$226.5K	Unusual size	SEC
BioAge Labs, Inc.Listing on record	Jan 15, 2026	Sell	-4,440	19.45 USD	$86.4K		SEC
BioAge Labs, Inc.Listing on record	Jan 15, 2026	Sell	-11,663	20.54 USD	$239.6K		SEC
Coya Therapeutics, Inc.Listing on record	Jan 6, 2026	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Coya Therapeutics, Inc.Listing on record	Aug 19, 2025	ExerciseD (derivative)	-17,557	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Coya Therapeutics, Inc.Listing on record	Aug 19, 2025	Exercise	17,557	1.09 USD	$19.1K		SEC
Gain Therapeutics, Inc.Listing on record	Jun 25, 2025	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Coya Therapeutics, Inc.Listing on record	Feb 25, 2025	AwardD (derivative)	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Feb 20, 2025	AwardD (derivative)	170,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Coya Therapeutics, Inc.Listing on record	Jan 3, 2025	AwardD (derivative)	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Gain Therapeutics, Inc.Listing on record	Jun 26, 2024	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Coya Therapeutics, Inc.Listing on record	Jan 19, 2024	AwardD (derivative)	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Gain Therapeutics, Inc.Listing on record	Jul 17, 2026	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Apr 24, 2026	ExerciseD (derivative)	-3,542	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Apr 24, 2026	Exercise	3,542	4.38 USD	$15.5K		SEC
BioAge Labs, Inc.Listing on record	Mar 3, 2026	ExerciseD (derivative)	-3,542	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Mar 3, 2026	Exercise	3,542	4.38 USD	$15.5K		SEC
BioAge Labs, Inc.Listing on record	Feb 19, 2026	AwardD (derivative)	110,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Feb 3, 2026	ExerciseD (derivative)	-3,541	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Feb 3, 2026	Exercise	3,541	4.38 USD	$15.5K		SEC
BioAge Labs, Inc.Listing on record	Jan 21, 2026	ExerciseD (derivative)	-3,542	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Jan 21, 2026	Exercise	3,542	4.38 USD	$15.5K		SEC
BioAge Labs, Inc.Listing on record	Jan 15, 2026	Sell	-8,974	18.43 USD	$165.4K		SEC
BioAge Labs, Inc.Listing on record	Jan 15, 2026	Sell	-1,923	21.08 USD	$40.5K		SEC
BioAge Labs, Inc.Listing on record	Jan 15, 2026	ExerciseD (derivative)	-27,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Jan 15, 2026	Exercise	27,000	8.39 USD	$226.5K	Unusual size	SEC
BioAge Labs, Inc.Listing on record	Jan 15, 2026	Sell	-4,440	19.45 USD	$86.4K		SEC
BioAge Labs, Inc.Listing on record	Jan 15, 2026	Sell	-11,663	20.54 USD	$239.6K		SEC
Coya Therapeutics, Inc.Listing on record	Jan 6, 2026	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Coya Therapeutics, Inc.Listing on record	Aug 19, 2025	ExerciseD (derivative)	-17,557	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Coya Therapeutics, Inc.Listing on record	Aug 19, 2025	Exercise	17,557	1.09 USD	$19.1K		SEC
Gain Therapeutics, Inc.Listing on record	Jun 25, 2025	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Coya Therapeutics, Inc.Listing on record	Feb 25, 2025	AwardD (derivative)	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Feb 20, 2025	AwardD (derivative)	170,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Coya Therapeutics, Inc.Listing on record	Jan 3, 2025	AwardD (derivative)	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Gain Therapeutics, Inc.Listing on record	Jun 26, 2024	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Coya Therapeutics, Inc.Listing on record	Jan 19, 2024	AwardD (derivative)	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC